Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Managing the Complexity of Modern Sterile Product Developments

February 16, 2024

Managing the intricacies of sterile product development is imperative for successful and compliant outcomes.

Navigating the Preclinical CRO Outsourcing Process

February 16, 2024

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

February 15, 2024

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Ensuring Quality in Contracted Support

February 15, 2024

This article looks at the relationship between a CDMO quality organization and the client.

How to Evaluate a CDMO’s Commitment to Quality

February 15, 2024

What do you need to ask during the vetting and selection process to ensure your clinical or commercial program won’t be derailed by a quality-related problem?

Biovian and 3P Biopharmaceuticals Combine to Form 3PBIOVIAN

February 05, 2024

The CDMOs are joining together to offer end-to-end development and manufacturing services for protein expression systems and viral vectors in Europe.

Addressing PK/PD Study Design Early in Development

February 02, 2024

Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.

Lonza and Oxford Nanopore Partner on mRNA Analytics

February 02, 2024

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

KBI Biopharma and Argonaut Manufacturing Services Team Up on Drug Substance and Drug Product Manufacturing Solutions

January 24, 2024

Under a new alliance, KBI Biopharma and Argonaut Manufacturing Services will combine their strengths to offer end-to-end biopharma development and CGMP manufacturing solutions.

Novartis Acquires Calypso Biotech for up to $425 Million

January 18, 2024

The acquisition will give Novartis full rights to CALY-002, Calypso’s lead product candidate.